REDUCING TB TREATMENT TO FOUR MONTHSOur trial, panTB-HM, responds to the Project to Accelerate New Treatments for Tuberculosis (PAN-TB). PAN-TB is a consortium of philanthropists seeking to accelerate the development of novel, shorter Tuberculosis treatments which are simpler to use and have better tolerability. panTB-HM, a phase 2c trial, will test Sutezolid at 2 dose [...]
